Loïc Simon

Loïc Simon

Auto-generated profile, based on publicly available information

Loïc Simon

Centre Méditerranéen de Médecine Moléculaire (C3M), U1065, Université Côte d’Azur, Inserm, 151 route Saint Antoine de Ginestière, BP 2 3194 06204, Nice, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
LSLoïc Simon
Loïc Simon
EUEstelle Ughetto
Estelle Ughetto
AGAlice Gaudart
Alice Gaudart
NDNicolas Degand
Nicolas Degand
Romain LotteRomain Lotte
Romain Lotte
RRRaymond Ruimy
Raymond Ruimy
MALDI-TOF Mass Spectrometry is not widely used to identify bacteria directly from positive blood culture bottles (BCBs) because of overlong protocols. The objective of this work was to develop and evaluate a simple extraction protocol for reliable identification from BCBs. The 10-minute protocol was applied over a five-month period. Direct identifications on Day0 were compared with those obtained from colonies on Day1 (log(score) ≥ 2). We evaluated a range of seven log(score) thresholds on Day0 from 1.4 to 2.0 to find the lower confidence score that provides the higher percentage of direct identifications without loss of accuracy. With a log(score) threshold ≥ 1.5 at Day0, our protocol allowed us to identify 80% of bacteria in 632 BCBs (96% of Enterobacteriaceae, 95% of Staphylococcus aureus, 92% of enterococci and 62% of streptococci). At least one bacterial species of the mixture was identified in 77% of the polymicrobial samples. The rapidity and reliability of the protocol were factors in its adoption for routine use, allowing us to save up to 24 hours in identifying 80% of the bacteria in the BCBs and thus to supply useful information to adapt antibiotic therapy when necessary. We currently provide reliable daily direct identifications of staphylococci, enterococci, Enterobacteriaceae, Pseudomonas aeruginosa and beta-hemolytic streptococci.

25 February 2020 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
MLMaude F. Lévêque
Maude F. Lévêque
LLLaurence Lachaud
Laurence Lachaud
LSLoïc Simon
Loïc Simon
EBEmilie Battery
Emilie Battery
PMPierre Marty
Pierre Marty
CPChristelle Pomares
Christelle Pomares
Leishmaniases are a group of parasitic diseases transmitted through the bite of female phlebotomine sandflies. Depending on the Leishmania species, the reservoirs can be humans (anthroponosis) or different animals (zoonosis). Zoonotic leishmaniasis present several clinical forms in function of the species involved: visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and muco-cutaneous leishmaniasis (MCL). The biological diagnosis is of utmost importance because the clinical features are not specific. In addition to parasitological and molecular biology (polymerase chain reaction, PCR) assays, serology is routinely used for the diagnosis of leishmaniasis. Indeed, although PCR is more sensitive than serological assays, its implementation is limited to referral laboratories and research centers. Therefore, serology is still a key element for their diagnosis. Here, we discuss the different serological assays available for the diagnosis of zoonotic leishmaniasis. We will review the enzyme-linked immunosorbent assay, immunofluorescence antibody test, immunochromatography test (ICT), direct agglutination test, and western blot as well as the different diagnostic strategies in function of the clinical form (VL, CL, and MCL). We will also discuss the place of serology for detecting asymptomatic carriers and for the follow-up of VL. Depending on the laboratory, different assays can be used, from ICT, which is appropriate for field testing, to a combination of serological tests to improve the sensitivity.

7 February 2020 in Parasite
Verified
Journal Article
Open access
PDF file
LSLoïc Simon
Loïc Simon
JFJudith Fillaux
Judith Fillaux
AGAurélie Guigon
Aurélie Guigon
RLRose-Anne Lavergne
Rose-Anne Lavergne
OVOdile Villard
Odile Villard
CPChristelle Pomares
Christelle Pomares
Background: Primary infection byToxoplasma gondiiin pregnant women can result in serious outcomes for the foetus. A false-positive IgG result during pregnancy can lead to a misdiagnosis of past infection and to stopping preventive measures. We collected 189 sera with positive Architect®Toxo IgG assay (Abbott Laboratories) and negative IgG results with at least two other serological tests, in order to find an explanation for the suspected false-positive IgG results. We used therecomLine Toxoplasma IgG®immunoblot (Mikrogen Diagnostik) to search for specific antigenic reactivities of the sera, and the LDBio Toxo II IgG®immunoblot (LDBio Diagnostics) as a confirmatory test.Results: The bands GRA8 and/or GRA7 were positive for 148 samples (78.3%). GRA8 was the most frequent band, appearing in 133 patterns (70.4%), whereas GRA7 was present for 49 samples (25.9%). Of the 81 samples tested with LDBio®, 23 (28.4%) turned out to be positive. Of the 58 negative LDBio®tests (71.6%) (real false-positive Architect®IgG), 23 samples (39.6%) did not show either a GRA8 or p30 band byrecomLine®. Their false positivity with Architect®remains unexplained since Abbott uses these two recombinant antigens for their assay.Conclusions: The Architect®IgG false positivity forT. gondiiseems to be due to reactivity against GRA8 for the majority of the sera and GRA7 to a lesser extent. The hypothesis of past contact with parasites genetically close toT. gondiisuch asHammondia hammondiorNeospora caninumseems promising and should be assessed further.

26 March 2024 in Parasite
Verified
Journal Article
Open access
PDF file
MHMallorie Hide
Mallorie Hide
GMGregory Michel
Gregory Michel
KLKevin Legueult
Kevin Legueult
RPRaphaelle Pin
Raphaelle Pin
SLSusana Leonard
Susana Leonard
CPChristelle Pomares
Christelle Pomares
The prevalence of asymptomatic leishmaniasis in dogs and their owners in the main endemic areas of France has not been studied to date. The objective of this study was to quantify asymptomatic Leishmania infantum infection in southeast France in healthy people and their dogs using molecular and serological screening techniques. We examined the presence of parasitic DNA using specific PCR targeting kinetoplast DNA (kDNA) and specific antibodies by serology (ELISA for dogs and Western blot for humans) among immunocompetent residents and their dogs in the Alpes-Maritimes. Results from 343 humans and 607 dogs were included. 46.9% (n = 161/343) of humans and 18.3% (n = 111/607) of dogs were PCR positive; 40.2% of humans (n = 138/343) and 9.9% of dogs (n = 60/607) were serology positive. Altogether, 66.2% of humans (n = 227) and 25.7% of dogs (n = 156) had positive serologies and/or positive PCR test results. Short-haired dogs were more frequently infected (71.8%, n = 112) than long-haired dogs (12.2%, n = 19) (p = 0.043). Dogs seemed to be more susceptible to asymptomatic infection according to their breed types (higher infection rates in scenthounds, gun dogs and herding dogs) (p = 0.04). The highest proportion of dogs and human asymptomatic infections was found in the Vence Region, corresponding to 28.2% (n = 20/71) of dogs and 70.5% (n = 31/44) of humans (4.5/100,000 people). In conclusion, the percentage of infections in asymptomatic humans is higher than in asymptomatic dogs in the studied endemic area. It is questionable whether asymptomatic infection in humans constitutes a risk factor for dogs.

3 February 2023 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
ALAnne Landreau
Anne Landreau
LSLoïc Simon
Loïc Simon
PDPascal Delaunay
Pascal Delaunay
CPChristelle Pomares
Christelle Pomares
LHLilia Hasseine
Lilia Hasseine
In France, onychomycoses represent about 30% of superficial mycoses seen by the dermatologists. In recent years, it is observed an increased number of mycoses due to non-dermatophytic molds. The purpose of this study was to evaluate the epidemiological profile of identified superficial fungal infections in the Laboratory of Parasitology-Mycology of the University Hospital of Nice over a two-year period. A retrospective study was performed from the nail, skin and scalp samples of patients analyzed from January 2018 to December 2019. In this study, 3074 samples (54.2% nails, 39.7% skin and 6.1% scalp) were analyzed representing 1922 patients. Among them, 809 (42.1%) patients were sampled by dermatologists and 1113 (57.9%) were sampled by our experts in the clinical unit of the University Hospital of Nice. In total, 1159 (37.7%) samples had a positive culture (1195 strains identified) including 712 (59.6%) dermatophytes, 345 (28.9%) yeasts and 138 (11.5%) other filamentous molds. Trichophyton rubrum was the main dermatophyte (563; 47.1%) followed by T. interdigitale (84; 7.0%) and T. soudanense (25; 2.1%). Yeasts were mostly represented by Candida albicans (155; 13.0%). Among the other molds, Fusarium sp. was the most isolated (61; 5.1%). Dermatophytes stay predominant in superficial fungal infections where the anthropophilic species T. rubrum was found in almost half of the positive cultures. Interestingly, molds represented an important part of infections in our population. This study highlights the increasing share of Fusarium sp. superficial fungal infection in our patients' populations, perhaps requiring a major therapeutic adaptation in the years to come. We assessed the epidemiological profile of superficial fungal infections in the Laboratory of Parasitology-Mycology of the Hospital of Nice, over a two-year period. Among our samples, dermatophytes remain predominant, mainly the species Trichophyton rubrum and we had a large proportion of Fusarium.

1 December 2021 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
LSLoïc Simon
Loïc Simon
TDTanguy Déméautis
Tanguy Déméautis
DDDamien Dupont
Damien Dupont
RKRolf Kramer
Rolf Kramer
HGHéloïse Garnier
Héloïse Garnier
JMJean Menotti
Jean Menotti